AstraZeneca's bid for Omthera Pharmaceuticals cleared by US antitrust officials
By Jeff Bliss ( June 27, 2013, 13:22 GMT | Insight) -- NYSE-listed AstraZeneca received approval from US antitrust authorities to buy Nasdaq-listed specialty pharmaceutical company Omthera Pharmaceuticals, according to a list released by the US Federal Trade Commission Thursday.NYSE-listed AstraZeneca received approval from US antitrust authorities to buy Nasdaq-listed specialty pharmaceutical company Omthera Pharmaceuticals, according to a list released by the US Federal Trade Commission Thursday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.